HISTOMORPHOLOGICAL ANALYSIS OF SUBEPIDERMAL BULLOUS DISORDERS OF SKIN BY PERIODIC ACID-SCHIFF STAIN

Main Article Content

Dr. Masilamithran.P
Dr. Keerthini Ganesan
Dr. Prathipaa.R
Dr. Aravind Sagar.M
Dr. Pavithra.R

Keywords

Subepidermal Bullous Disorders, Histomorphology, PAS Stain, Dermatopathology, Basement Membrane Zone, Bullous Pemphigoid, Skin Biopsy, Histopathology

Abstract

Background: Subepidermal bullous illnesses are autoimmune blistering diseases that exhibit notable clinicopathological overlap and separation at the dermoepidermal junction. For proper diagnosis and treatment, accurate distinction is crucial. The basement membrane zone can be highlighted by Periodic Acid–Schiff (PAS) stain, which can help determine the degree of separation.


Aim: Examine the histomorphological characteristics of subepidermal bullous diseases and assess the diagnostic value of PAS staining.


Materials and Methods: As part of this prospective investigation, 40 skin samples from clinically suspected bullous disorders were assessed over a one-year period using PAS and Hematoxylin and Eosin staining. Histomorphology, PAS staining patterns, and inflammatory infiltration were evaluated and linked to the diagnosis.


Results: With a female preponderance, bullous pemphigoid was the most prevalent entity (65%). Subepidermal blisters formed in all patients with the most common pattern being an eosinophil-rich infiltration (55%). In every instance, PAS staining brought attention to the basement membrane zone displaying a floor pattern in 80% of cases and a roof pattern in 20%. Whereas the roof pattern was observed in porphyria cutanea tarda, bullous lupus erythematosus, and epidermolysis bullosa acquisita, floor staining was primarily associated with bullous pemphigoid and lichen planus pemphigoides.


Conclusion: In conclusion, PAS provides a straight forward and reasonably priced addition to standard histology for the differentiation of subepidermal bullous diseases.


 


 

Abstract 0 | pdf Downloads 0

References

1. Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunol Res. 2018 Feb;66(1):6-17. doi: 10.1007/s12026-017-8975-2. PMID: 29159697.
2. Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381: 320–332. doi:10.1016/s0140-6736(12)61140-4
3. Serwin AB, Musialkowska E, Piascik M (2014) Incidence and mortality of bullous pemphigoid in north-east Poland (Podlaskie Province), 1999-2012: a retrospective bicentric cohort study. Int J Dermatol 53:e432–e437. doi:10.1111/ijd.12492
4. Marazza G, Pham HC, Scharer L, Pedrazzetti PP, Hunziker T, Trueb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L (2009) Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 161:861– 868. doi:10.1111/j.1365-2133.2009.09300.x
5. Feliciani, C., et al., Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol, 2015. 172(4): p. 867-77.
6. de la Fuente, S., et al., Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review. Pediatr Dermatol, 2013.
7. Joly, P., et al., A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med, 2002. 346
8. Christoph M. Hammers, John R. Stanley. 2016. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid. Annual Review Pathology: Mechanisms Disease. 11:175-197. https://doi.org/10.1146/annurev-pathol-012615-044313
9. Abreu Velez AM, Upegui Zapata YA, Howard MS. Periodic Acid-Schiff Staining Parallels the Immunoreactivity Seen By Direct Immunofluorescence in Autoimmune Skin Diseases. N Am J Med Sci. 2016 Mar;8(3):151-5. doi: 10.4103/1947-2714.179132. PMID: 27114972; PMCID: PMC4821094.
10. Warnock ML, Stoloff A, Thor A. Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-schiff, monoclonal antibodies B72.3, and Leu M1. Am J Pathol. 1988;133:30–8.
11. Carson FL, Hladik C. 3rd ed. Hong Kong: American Society for Clinical Pathology Press; 2009. Histotechnology: A Self-Instructional Text; pp. 137–9.
12. Ponmar, Madhurima; Sathishkumar, Dharshini1; Pulimood, Susanne Alexander1; Thomas, Meera. Patterns of Periodic Acid–Schiff Staining in Subepidermal Bullous Disorders with Emphasis on Bullous Pemphigoid. Current Medical Issues 22(1):p 1-6, Jan–Mar 2024. | DOI: 10.4103/cmi.cmi_69_23
13. Gardner KM, Crawford RI. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence. J Cutan Med Surg. 2018 Jan/Feb;22(1):22-24. doi: 10.1177/1203475417722734. Epub 2017 Jul 18. PMID: 28719980.
14. Sindhoor , Rai S, A DAS. Periodic acid-schiff staining: A counterpart of the immunoreactivity seen by direct immunofluorescence in bullous pemphigoid [Internet]. Indian J Pathol Oncol. 2024 [cited 2026 Feb 23];11(3):238-242. Available from: https://doi.org/10.18231/j.ijpo.2024.054
15. Shalin, S. C., Ferringer, T., & Cassarino, D. S. (2020). PAS and GMS utility in dermatopathology: review of the current medical literature. Journal of Cutaneous Pathology, 47(11), 1096-1102.
16. Ponmar, Madhurima, et al. "Patterns of Periodic Acid–Schiff Staining in Subepidermal Bullous Disorders with Emphasis on Bullous Pemphigoid." Current Medical Issues 22.1 (2024): 1-6.
17. Deepti S Punneshetty1 , Suba G2 , Shaista Choudhary3 , Manjunatha Y A,(2022) HISTMORPHOLOGICAL PROFILE AND DIRECT IMMUNOFLORESENCE IN SUBEPIDERMAL BULLOUS LESION OF SKIN. DOI: 10.47009/jamp.2022.4.5.51
18. Hodge BD, Roach J, Reserva JL, Patel T, Googe A, Schulmeier J, Brodell RT. The spectrum of histopathologic findings in pemphigoid: Avoiding diagnostic pitfalls. J Cutan Pathol. 2018 Nov;45(11):831-838. doi: 10.1111/cup.13343. Epub 2018 Sep 19. PMID: 30141231.
19. Chen H, Hou PC, Hsu SH, Huang HY, Chen WR, Hsu CK, Lee JY. Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role. J Dermatol. 2026 Feb;53(2):245-252. doi: 10.1111/1346-8138.70053. Epub 2025 Nov 17. PMID: 41246878.
20. Baigrie D, Nookala V. Bullous Pemphigoid. 2023 Mar 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30570995.